Synthesis, cytotoxic activity, and computational analysis of N10-substituted acridone analogs

Keyphrases

• A549 66%
• Acridone 100%
• Acridone Derivatives 33%
• Active Sites 33%
• Activity Analysis 100%
• Anticancer Drugs 33%
• ATP Binding Site 33%
• Carcinoma 33%
• Computational Analysis 100%
• Cytotoxic Activity 100%
• Docking Simulation 66%
• Dual Action 33%
• HeLa Cancer Cells 33%
• HeLa Cell Line 33%
• HT-29 66%
• Human Breast Adenocarcinoma 33%
• Human Cervical Spine 33%
• Human Colon Adenocarcinoma 33%
• In Silico Study 33%
• In Vitro Activity 33%
• In Vitro Cytotoxicity 66%
• MCF-7 66%
• Modulated Potential 33%
• MTT Assay 33%
• Multidrug Resistance 100%
• P-glycoprotein (P-gp) 33%
• Small Cell Lung Carcinoma 33%
• Synthesized Compounds 33%

Medicine and Dentistry

• Acridone Derivative 100%
• Adenosine Triphosphate 33%
• Binding Site 33%
• Breast Adenocarcinoma 33%
• Cancer Cell Line 33%
• Carcinoma 33%
• Colon Adenocarcinoma 33%
• Cytotoxicity 100%
• HeLa Cell Line 33%
• HT-29 Cell Line 33%
• In Silico 33%
• In Vitro 100%
• Malignant Neoplasm 33%
• MCF-7 66%
• MTT Assay 33%
• Multidrug Resistance 100%
• Small Cell Lung Cancer 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acridone Derivative 100%
• Adenosine Triphosphate 33%
• Binding Site 33%
• Breast Adenocarcinoma 33%
• Carcinoma 33%
• Colon Adenocarcinoma 33%
• Cytotoxicity 100%
• Malignant Neoplasm 66%
• Multiple Drug Resistance 100%
• Small Cell Lung Cancer 33%